Sat, Sep 20, 2014, 7:06 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Alliqua, Inc. Message Board

  • sweetliberty17761776 sweetliberty17761776 Feb 10, 2014 9:19 AM Flag

    Some info about the new Dr.

    Alliqua, Inc. (NASDAQ:ALQA) ("Alliqua" or "the Company") has appointed Janice M. Smiell, M.D. as its Chief Medical Officer, a newly created position.

    Dr. Smiell has more than two decades of experience in clinical trial design, clinical development and planning, and clinical regulatory submissions. In practice as a general surgeon, she has specialized in wound healing, wound care and trauma. Most recently, she was an independent consultant in drug, device, tissue and cells clinical development planning, as well as medical monitoring and management. Prior to this, she served as VP, Medical Affairs at LifeCell Corporation, where she established the clinical operations, biometrics and safety departments. Earlier, as Executive Director of Clinical R&D at Celgene Corporation, she initially led the clinical development of biomaterials and stem cells and subsequently oversaw research teams developing immune modulators in several indications. She also served in various positions of increasing responsibility at The R.W. Johnson Pharmaceutical Research Institute, including Senior Director, Global Clinical R&D. Prior to this, she served as Medical Director of The Wound Care Center at Morristown Memorial Hospital. She holds an M.D. degree from the Medical College of Pennsylvania.

    Dr. Smiell said, "As a veteran of the wound healing and wound care space, I am acutely aware of the need for significant innovation in this area. I am extremely enthusiastic about Alliqua's vision of offering a suite of products that target a broad spectrum of wound conditions. I am greatly looking forward to working with Alliqua's management team to help evaluate new technologies and expand the company's portfolio to address diverse wound care needs, as well as to coordinate our clinical trials."

    David Johnson, Chief Executive Officer of Alliqua, said, "Dr. Janice Smiell brings a tremendous amount of management and clinical experience to Alliqua, and we are honored to have her serve as our Chief Med

 
ALQA
4.92-0.08(-1.60%)Sep 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.